MedTrace Logo

the Standardized Training Program for Social Workers

NCT05053516 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-09-22

No results posted yet for this study

Summary

Now, there are few researches on the ability of social workers who work with drug addicts / drug users in China, and the sample size is small and the content is not deep enough.The existing studies suggest that the professional knowledge and ability of social workers who work with drug addicts / drug users are insufficient and the vocational training is not standardized. On the other hand, the ability of social workers who work with drug addicts / drug users workers is related to the effectiveness of anti-drug in communities. So the large sample survey will help to understand the current working status and working ability of social workers who work with drug addicts / drug users in China.The development of the standardized training programs for social workers who work with drug addicts / drug users can improve the professional knowledge and ability of anti-drug social workers, so as to better help community drug rehabilitation personnel and finally reduce the relapse rate.

Conditions

  • Social Workers
  • Educational Problems

Interventions

OTHER

A standardized training program for social workers

A standardized training program for social workers who work with drug addicts / drug users based on industry needs

Sponsors & Collaborators

  • Shanghai Mental Health Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05053516 on ClinicalTrials.gov